Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

OptimizeRx (OPRX) Shares Repurchased (2016 - 2024)

OptimizeRx's Shares Repurchased history spans 5 years, with the latest figure at $1.6 million for Q4 2024.

  • For Q4 2024, Shares Repurchased rose 510.96% year-over-year to $1.6 million; the TTM value through Dec 2024 reached $6.7 million, up 0.65%, while the annual FY2024 figure was $6.7 million, 14.23% down from the prior year.
  • Shares Repurchased for Q4 2024 was $1.6 million at OptimizeRx, up from $1.6 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $12.2 million in Q3 2022 and bottomed at $269574.0 in Q4 2023.
  • The 3-year median for Shares Repurchased is $1.7 million (2024), against an average of $3.3 million.
  • The largest annual shift saw Shares Repurchased plummeted 96.39% in 2023 before it surged 510.96% in 2024.
  • A 3-year view of Shares Repurchased shows it stood at $7.5 million in 2022, then tumbled by 96.39% to $269574.0 in 2023, then soared by 510.96% to $1.6 million in 2024.
  • Per Business Quant, the three most recent readings for OPRX's Shares Repurchased are $1.6 million (Q4 2024), $1.6 million (Q3 2024), and $1.8 million (Q2 2024).